Stocks · NASDAQ · Healthcare · United States

ALNY — Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc. (ALNY) is a healthcare stock listed on NASDAQ (United States). At the close of September 29, 2026 it traded at 254.07 (-0.51% on the day), +5.6% over one month, -15.8% over three months, -43.2% over twelve months. The InvestMuse composite score is +26 on a −100 to +100 scale, a mixed read that ranks #394 of about 1,221 assets. The strongest of its nine dimensions are Fundamentals (+46) and Sector edge (+36); the weakest is Chart patterns and zones (-100). Its volatility regime from the hidden Markov model is Hot. 7 news articles in the last 30 days carried an average tone of +0.39 (on −1 to +1).

Open the interactive read →Race ALNY with $100k play money

The facts

Last close254.07 (September 29, 2026)
1 day / 1 month / 3 months / 12 months-0.51% / +5.6% / -15.8% / -43.2%
52-week range205.48 – 491.22
Composite score+26 / 100 · mixed view · rank #394
Volatility regime (HMM)Hot
Support levels75.00
Resistance levels145.00
Trailing P/E51.5
Market cap$41.6B

The nine dimensions

Each dimension is scored from −100 to +100; the composite is their weighted blend. Composite of 9 dimensions; not a recommendation.

How this read is made

Every night InvestMuse scores about 1,221 stocks, crypto assets, currencies, commodities and indices on nine dimensions: a hidden Markov model regime, technical indicators, trend, support and resistance from price clustering, fundamentals, the gap to sector peers, news sentiment, momentum, and chart patterns with demand/supply zones and Fibonacci levels. Members race each other with $100,000 of play money, against five fictional fund managers and the InvestMuse algorithm.

Data as of September 29, 2026. Observations from public market data — not investment advice, not a recommendation to buy or sell.